“PROSPECTS FOR HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE FIRST LINE OF THERAPY FOR AGGRESSIVE NON-HODGKIN’S LYMPHOMAS”, Вопр. онкол., vol. 63, no. 2, pp. 326–328, Feb. 2017, doi: 10.37469/0507-3758-2017-63-2-326-328.